Nanox Expands U.S. Reach with New Distribution Deal for Nanox.ARC Systems
NNOX is trading near its 52-week low of $1.94 (5.4% above the low) on elevated volume (3.8× avg).
Summary
Nano-X Imaging (NNOX) announced a new distribution agreement with Radiology Oncology Systems to expand the adoption of its FDA-cleared Nanox.ARC systems across the United States. This partnership is a continuation of Nanox's strategy to build its U.S. commercial footprint through targeted distribution agreements, following similar announcements earlier this month. The deal leverages Radiology Oncology Systems' established network, particularly in diagnostic imaging and oncology equipment solutions, to broaden access to Nanox's 3D imaging technology. While specific deployment numbers were not disclosed, this agreement signifies ongoing progress in commercializing the Nanox.ARC, which is critical for the company's revenue growth, especially after the recent report of a significant net loss for Q4 2025.
At the time of this announcement, NNOX was trading at $2.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $139.2M. The 52-week trading range was $1.94 to $5.86. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.